207 related articles for article (PubMed ID: 9555358)
1. Focus on insulin resistance in type 2 diabetes: therapeutic implications.
Reusch JE
Diabetes Educ; 1998; 24(2):188-93. PubMed ID: 9555358
[TBL] [Abstract][Full Text] [Related]
2. Type II diabetes mellitus.
Edelman SV
Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of type 2 diabetes and its relationship to new therapeutic approaches.
Bell D
Diabetes Educ; 2000; 26 Suppl():4-7. PubMed ID: 11912815
[No Abstract] [Full Text] [Related]
4. [Non-insulin-dependent diabetes: from physiopathology to treatment].
Scheen AJ; Lefebvre PJ
Bull Mem Acad R Med Belg; 1996; 151(7-9):395-402; discussion 402-5. PubMed ID: 9221054
[TBL] [Abstract][Full Text] [Related]
5. [Insulin secretion and repaglinide].
Owens D
Diabetes Metab; 1999 Dec; 25 Suppl 7():17-9. PubMed ID: 10746006
[TBL] [Abstract][Full Text] [Related]
6. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
7. Effects of current therapeutic interventions on insulin resistance.
Kobayashi M
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S32-40. PubMed ID: 11220286
[TBL] [Abstract][Full Text] [Related]
8. Treatment of type 2 diabetes mellitus in children and adolescents.
Silverstein JH; Rosenbloom AL
J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1403-9. PubMed ID: 11202216
[TBL] [Abstract][Full Text] [Related]
9. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
10. Therapy for type 2 diabetes mellitus.
Elson DF; Meredith M
WMJ; 1998 Mar; 97(3):49-54. PubMed ID: 9540451
[TBL] [Abstract][Full Text] [Related]
11. [Rational therapy of Type II diabetes].
Hanefeld M; Fischer S
Ther Umsch; 1996 Dec; 53(12):914-24. PubMed ID: 9036569
[TBL] [Abstract][Full Text] [Related]
12. New oral therapies for type 2 diabetes.
Purnell JQ; Hirsch IB
Am Fam Physician; 1997 Nov; 56(7):1835-42. PubMed ID: 9371013
[TBL] [Abstract][Full Text] [Related]
13. Treating dual defects in diabetes: insulin resistance and insulin secretion.
Bohannon NJ
Am J Health Syst Pharm; 2002 Dec; 59 Suppl 9():S9-13. PubMed ID: 12489381
[TBL] [Abstract][Full Text] [Related]
14. [Etiopathogenesis, physiopathology and general principles of therapy of type II diabetes].
Scheen A; Lefèbvre PJ
Rev Med Liege; 1988 Apr; 43(7):205-11. PubMed ID: 3287543
[No Abstract] [Full Text] [Related]
15. Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?
van Raalte DH; Verchere CB
Diabetes Obes Metab; 2017 Sep; 19(9):1205-1213. PubMed ID: 28295962
[TBL] [Abstract][Full Text] [Related]
16. [Etiology of and therapy for type-2 diabetes mellitus].
Kazuga M
Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):527-31. PubMed ID: 15052815
[No Abstract] [Full Text] [Related]
17. [Therapies for newly-onset diabetic patients].
Kawamori R
Nihon Rinsho; 2005 Feb; 63 Suppl 2():525-32. PubMed ID: 15779435
[No Abstract] [Full Text] [Related]
18. Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions.
Dagogo-Jack S; Santiago JV
Arch Intern Med; 1997 Sep; 157(16):1802-17. PubMed ID: 9290539
[TBL] [Abstract][Full Text] [Related]
19. Glucose control and insulin resistance in non-insulin-dependent diabetes mellitus.
Henry RR
Ann Intern Med; 1996 Jan; 124(1 Pt 2):97-103. PubMed ID: 8554221
[TBL] [Abstract][Full Text] [Related]
20. Linagliptin/Metformin fixed-dose combination treatment: a dual attack to type 2 diabetes pathophysiology.
Koliaki C; Doupis J
Adv Ther; 2012 Dec; 29(12):993-1004. PubMed ID: 23184570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]